“Nakatanggap na kami ng report mula sa Ateneo kay Dr. Fabian Dayrit na natapos na ‘yung testing in vitro trials for the efficacy of lauric acid and its derivatives versus SARS-CoV-2 ,” he said.
The initial results of the study showed that monolaurin and lauric acid exhibited a modest antiviral activity against SARS-CoV-2 virus in vitro. Dela Pena said that since these compounds are components of food and are generally recognized as safe , these experiments justify further studies on the use of VCO as supportive treatment for COVID-19.The first is at the Sta.
The second trial is at the Philippine General Hospital , where 50 patients will take VCO while 50 others will not. During the trial, the VCO will serve as a supplement to the daily treatment regimen of the COVID-19 positive patients. The study aims to assess the possible benefits of VCO if given to patients with moderate to severe COVID-19 in addition to the drugs being assessed in the clinical trials.
The third is in Singapore where the study will determine whether certain coconut oil components can diminish or prevent the infectivity of SARS-CoV2, the causative virus of COVID-19.